KRM Ayurveda Limited Crosses JPY 100+ Crore Revenue Milestone in FY26; H2 FY26 EBITDA Grows ~100% YoY and PAT Surges ~149%, with PAT Margins Nearly Doubling

PNN, Capital strengthening, Digital health, Wellness tourism, Consumer trust, Product portfolio, Advertorial Disclaimer
Business
image